Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

Clinical trial NCT06844565 · COMPLETED

Trial details

NCT number: NCT06844565
Sponsor: Tanta University
Status: COMPLETED
Study type: OBSERVATIONAL

Interleukin 12 Interleukin 23 Biomarker Diagnosis Crohn Disease

Start date: 2021-01-01
Primary completion: 2023-12-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.